1194P - Translational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A)
| Autor: | Diamond, J.R., Standifer, N., Ascierto, M.L., Morehouse, C., Ghadially, H., Rodriguez Canales, J., Rebelatto, M.C., Naidoo, J., Mazzarella, L., Patel, S., Flor Oncala, M.J., Alonso Gordoa, T., Wang, D., Song, X., Jones, D.C., Li, X., Marshall, S., Abdullah, S., Jure-Kunkel, M., Hellmann, M.D. |
|---|---|
| Zdroj: | In Annals of Oncology October 2018 29 Supplement 8 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|